Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Endocrine 1

Conditions

Obesity 8Multiple Endocrine Neoplasia Type 1 3Polycystic Ovary Syndrome 2Overweight 2Motor Activity 2Weight Loss 1Sexual Dysfunction, Physiological 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Inflammation 1Infertility 1Breast Neoplasms 1Body Weight Changes 1

Interventions

Exercise 6Nutrition Assessment 4Counseling 4Methods 3Caloric Restriction 3Tirzepatide 2Resistance Training 2Naltrexone 2Metformin 2Megestrol Acetate 2Exenatide 2Educational Status 2Early Intervention, Educational 2Diet 2Cognitive Behavioral Therapy 2Bupropion 2Blood Specimen Collection 2semaglutide 1licogliflozin 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Trehalase 1Tablets 1Standard of Care 1Psychology, Positive 1Propofol 1Progestins 1Patient Navigation 1Motivational Interviewing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Overweight × Diet × Other × Clear all
NCT01509066 2019-04-18

HERHealth

University of South Carolina

Phase NA Completed
18 enrolled
Other

Infertility, Obesity, Polycystic Ovary Syndrome, Overweight

NCT00412633 2012-06-11

Clinical & Web-based Diet & Activity Counseling for Men

University of California, San Diego

Phase NA Completed
442 enrolled
EndocrineOther

Obesity, Multiple Endocrine Neoplasia Type 1, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡